Quantum DrBIO Platform Starts NFT Revolution in Healthcare!

Innovations brought by the digital age are also rapidly developing the healthcare sector. AVB Biotech, the first two diamonds of the Quantum DrBIO Platform, is initiating a new development by offering treatment rights for all fatal diseases for which it has found treatment in the form of NFT certificates.

It is thought that with the spread of treatment rights for many risky diseases worldwide, it will be of great importance in ensuring that patients have access to treatment and in preventing victimization in this regard. These NFT certificates, which offer the opportunity to be exchanged with $DrBIO, also offer a new burning and mining model in this field.

Treatment Rights Defined with NFTs

With this initiative, treatment rights are being converted into NFT for the first time in the world. Thus, an asset-based NFT is created. It paves the way for the creation of measurable value by ensuring that the underlying asset is real and based on need.

COVID-19, AIDS-HIV, Hepatitis B, Sepsis, Tuberculosis and Cholera

In the first stage of this revolutionary change, treatment rights for COVID-19, AIDS-HIV, Hepatitis B, Sepsis, Tuberculosis and Cholera are being converted into NFT. In the system where each treatment right certificate is positioned as an NFT, it is aimed to use approximately 300 million NFTs only for these 6 diseases in 10 years.

However, AVB Biotech plans to switch to NFT production for other diseases during the registration phase in the future.

Swap Transactions with $DrBIO

At the heart of these innovations lies $DrBIO. $DrBIO is used for the generation and exchange of NFT certificates. In this way, economic balance is achieved by establishing a mining and burning mechanism. Quantum DRBIO platform is preparing for a launch where it will introduce this new model and NFTs to the whole world very soon.